Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma

Cancer Genetics and Cytogenetics

Volumn 172, Issue 1, 2007, Pages 12-22

  Szuhai, Károly ^a   IJszenga, Marije ^a   Tanke, Hans J ^a   Taminiau, Antonie H M ^a   de Schepper, Arthur ^a   van Duinen, Sjoerd G ^a   Rosenberg, Carla ^a   Hogendoorn, Pancras C W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHEMICAL LABELING; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; EWING SARCOMA; FLUORESCENCE ANALYSIS; GENE AMPLIFICATION; GENE TRANSLOCATION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMERUS; IN SITU HYBRIDIZATION; KARYOTYPE; MALE; PRIORITY JOURNAL; RING CHROMOSOME;

ADULT; BONE NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 22; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; RING CHROMOSOMES; RNA-BINDING PROTEIN EWS; SARCOMA, EWING'S; TRANSLOCATION, GENETIC;

EID: 33845401210     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.07.007     Document Type: Article

References (33)

1. Ushigome S., Machinami R., and Sorensen P.H. Ewing sarcoma/primitive neuroectodermal tumour. In: Fletcher C.D.M., Unni K.K., and Mertens F. (Eds) (2002), IARC Press, Lyon
2. Sandberg A.A., and Bridge J.A. Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors. Cancer Genet Cytogenet 123 (2000) 1-26
3. May W.A., Lessnick S.L., Braun B.S., Klemsz M., Lewis B.C., Lunsford L.B., Hromas R., and Denny C.T. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol 13 (1993) 7393-7398
4. Turc-Carel C., Philip I., Berger M.P., Philip T., and Lenoir G.M. Chromosome study of Ewing's sarcoma (ES) cell lines. Consistency of a reciprocal translocation t(11;22)(q24;q12). Cancer Genet Cytogenet 12 (1984) 1-19
5. Turc-Carel C., Aurias A., Mugneret F., Lizard S., Sidaner I., Volk C., Thiery J.P., Olschwang S., Philip I., and Berger M.P. Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet Cytogenet 32 (1988) 229-238
6. Zoubek A., Pfleiderer C., Salzer-Kuntschik M., Amann G., Windhager R., Fink F.M., Koscielniak E., Delattre O., Strehl S., and Ambros P.F. Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data. Br J Cancer 70 (1994) 908-913
7. Sorensen P.H., Lessnick S.L., Lopez-Terrada D., Liu X.F., Triche T.J., and Denny C.T. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 6 (1994) 146-151
8. Delattre O., Zucman J., Plougastel B., Desmaze C., Melot T., Peter M., Kovar H., Joubert I., De Jong P., and Rouleau G. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359 (1992) 162-165
9. Peter M., Couturier J., Pacquement H., Michon J., Thomas G., Magdelenat H., and Delattre O. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14 (1997) 1159-1164
10. Jeon I.S., Davis J.N., Braun B.S., Sublett J.E., Roussel M.F., Denny C.T., and Shapiro D.N. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10 (1995) 1229-1234
11. Kaneko Y., Yoshida K., Handa M., Toyoda Y., Nishihira H., Tanaka Y., Sasaki Y., Ishida S., Higashino F., and Fujinaga K. Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosomes Cancer 15 (1996) 115-121
12. Urano F., Umezawa A., Hong W., Kikuchi H., and Hata J. A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. Biochem Biophys Res Commun 219 (1996) 608-612
13. Szuhai K., Ijszenga M., Tanke H.J., Rosenberg C., and Hogendoorn P.C.W. Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines. Cancer Genet Cytogenet 166 (2006) 173-179
14. de Alava E., Kawai A., Healey J.H., Fligman I., Meyers P.A., Huvos A.G., Gerald W.L., Jhanwar S.C., Argani P., Antonescu C.R., Pardo-Mindan F.J., Ginsberg J., Womer R., Lawlor E.R., Wunder J., Andrulis I., Sorensen P.H., Barr F.G., and Ladanyi M. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 16 (1998) 1248-1255
15. Tanke H.J., Wiegant J., van Gijlswijk R.P., Bezrookove V., Pattenier H., Heetebrij R.J., Talman E.G., Raap A.K., and Vrolijk J. New strategy for multi-colour fluorescence in situ hybridisation: COBRA: COmbined Binary RAtio labelling. Eur J Hum Genet 7 (1999) 2-11
16. Szuhai K., Bezrookove V., Wiegant J., Vrolijk J., Dirks R.W., Rosenberg C., Raap A.K., and Tanke H.J. Simultaneous molecular karyotyping and mapping of viral DNA integration sites by 25-color COBRA-FISH. Genes Chromosomes Cancer 28 (2000) 92-97
17. Knijnenburg J., Szuhai K., Giltay J., Molenaar L., Sloos W., Poot M., Tanke H.J., and Rosenberg C. Insights from genomic microarrays into structural chromosome rearrangements. Am J Med Genet A 132 (2005) 36-40
18. Fiegler H., Carr P., Douglas E.J., Burford D.C., Hunt S., Scott C.E., Smith J., Vetrie D., Gorman P., Tomlinson I.P., and Carter N.P. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 36 (2003) 361-374
19. Hazelbag H.M., van Den Broek L.J., van Dorst E.B., Offerhaus G.J., Fleuren G.J., and Hogendoorn P.C.W. Immunostaining of chain-specific keratins on formalin-fixed, paraffin-embedded tissues: a comparison of various antigen retrieval systems using microwave heating and proteolytic pre-treatments. J Histochem Cytochem 43 (1995) 429-437
20. Hogendoorn P.C.W., de Heer E., Weening J.J., Daha M.R., Hoedemaeker P.J., and Fleuren G.J. Glomerular capillary wall charge and antibody binding in passive Heymann nephritis. J Lab Clin Med 111 (1988) 150-157
21. Peter M., Gilbert E., and Delattre O. A multiplex real-time pcr assay for the detection of gene fusions observed in solid tumors. Lab Invest 81 (2001) 905-912
22. Bezrookove V., Smits R., Moeslein G., Fodde R., Tanke H.J., Raap A.K., and Darroudi F. Premature chromosome condensation revisited: a novel chemical approach permits efficient cytogenetic analysis of cancers. Genes Chromosomes Cancer 38 (2003) 177-186
23. Shaffer L.G., and Tommerup N. ISCN. An international system for human cytogenetic nomenclature (2005), S. Karger, Basel
24. Hiller B., Bradtke J., Balz H., and Rieder H. CyDAS: a cytogenetic data analysis system. Bioinformatics 21 (2005) 1282-1283
25. Zucman J., Delattre O., Desmaze C., Plougastel B., Joubert I., Melot T., Peter M., De Jong P., Rouleau G., and Aurias A. Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints. Genes Chromosomes Cancer 5 (1992) 271-277
26. Hazelbag H.M., Szuhai K., Tanke H.J., Rosenberg C., and Hogendoorn P.C.W. Primary synovial sarcoma of the heart: a cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH of a case with a complex karyotype. Mod Pathol 17 (2004) 1434-1439
27. Davis R.J., and Barr F.G. Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Proc Natl Acad Sci U S A 94 (1997) 8047-8051
28. Mastrangelo T., Modena P., Tornielli S., Bullrich F., Testi M.A., Mezzelani A., Radice P., Azzarelli A., Pilotti S., Croce C.M., Pierotti M.A., and Sozzi G. A novel zinc finger gene is fused to EWS in small round cell tumor. Oncogene 19 (2000) 3799-3804
29. Tomlins S.A., Rhodes D.R., Perner S., Dhanasekaran S.M., Mehra R., Sun X.W., Varambally S., Cao X., Tchinda J., Kuefer R., Lee C., Montie J.E., Shah R.B., Pienta K.J., Rubin M.A., and Chinnaiyan A.M. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310 (2005) 644-648
30. Ohtani N., Zebedee Z., Huot T.J., Stinson J.A., Sugimoto M., Ohashi Y., Sharrocks A.D., Peters G., and Hara E. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409 (2001) 1067-1070
31. Wei G., Antonescu C.R., de Alava E., Leung D., Huvos A.G., Meyers P.A., Healey J.H., and Ladanyi M. Prognostic impact of INK4A deletion in Ewing sarcoma. Cancer 89 (2000) 793-799
32. Huang H.Y., Illei P.B., Zhao Z., Mazumdar M., Huvos A.G., Healey J.H., Wexler L.H., Gorlick R., Meyers P., and Ladanyi M. Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse. J Clin Oncol 23 (2005) 548-558
33. Kovar H., Jug G., Aryee D.N., Zoubek A., Ambros P., Gruber B., Windhager R., and Gadner H. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Oncogene 15 (1997) 2225-2232